Piezo1 could also be employed for immunotherapy, especial using CAR for selective activation or modulating of several immune cells like monocyte/macrophage and T-cells either systemic or locally, to treat atherosclerosis and other CVDs, including COVID-19 and cancer as already reported for different cancer treatment strategies. The gene discussed is PIEZO1; the disease is COVID-19.